208 related articles for article (PubMed ID: 19220413)
1. Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model.
Aujla PK; Fetell MR; Jensen FE
Epilepsia; 2009 Apr; 50(4):694-701. PubMed ID: 19220413
[TBL] [Abstract][Full Text] [Related]
2. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury.
Koh S; Tibayan FD; Simpson JN; Jensen FE
Epilepsia; 2004 Jun; 45(6):569-75. PubMed ID: 15144420
[TBL] [Abstract][Full Text] [Related]
3. Topiramate blocks perinatal hypoxia-induced seizures in rat pups.
Koh S; Jensen FE
Ann Neurol; 2001 Sep; 50(3):366-72. PubMed ID: 11558793
[TBL] [Abstract][Full Text] [Related]
4. Pre- and post-exposure talampanel (GYKI 53773) against kainic acid seizures in neonatal rats.
Dhir A; Chavda V
Pharmacol Rep; 2016 Feb; 68(1):190-5. PubMed ID: 26721372
[TBL] [Abstract][Full Text] [Related]
5. Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures.
Rakhade SN; Zhou C; Aujla PK; Fishman R; Sucher NJ; Jensen FE
J Neurosci; 2008 Aug; 28(32):7979-90. PubMed ID: 18685023
[TBL] [Abstract][Full Text] [Related]
6. AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures.
Lippman-Bell JJ; Rakhade SN; Klein PM; Obeid M; Jackson MC; Joseph A; Jensen FE
Epilepsia; 2013 Nov; 54(11):1922-32. PubMed ID: 24117347
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the antiepileptic drug candidate talampanel against AMPA-induced striatal neurotoxicity in neonatal rats.
Világi I; Takács J; Gulyás-Kovács A; Banczerowski-Pelyhe I; Tarnawa I
Brain Res Bull; 2002 Oct; 59(1):35-40. PubMed ID: 12372546
[TBL] [Abstract][Full Text] [Related]
8. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
9. Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466.
Fritsch B; Stott JJ; Joelle Donofrio J; Rogawski MA
Epilepsia; 2010 Jan; 51(1):108-17. PubMed ID: 19682025
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model.
Talos DM; Chang M; Kosaras B; Fitzgerald E; Murphy A; Folkerth RD; Jensen FE
Pediatr Res; 2013 Jan; 73(1):24-30. PubMed ID: 23138400
[TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.
Yamaguchi S; Donevan SD; Rogawski MA
Epilepsy Res; 1993 Jul; 15(3):179-84. PubMed ID: 7693450
[TBL] [Abstract][Full Text] [Related]
12. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
[TBL] [Abstract][Full Text] [Related]
13. Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats.
Borowicz KK; Duda AM; Kleinrok Z; Czuczwar SJ
Pol J Pharmacol; 2001; 53(2):101-8. PubMed ID: 11787948
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models.
Gigler G; Móricz K; Agoston M; Simó A; Albert M; Benedek A; Kapus G; Kertész S; Vegh M; Barkóczy J; Markó B; Szabó G; Matucz E; Gacsályi I; Lévay G; Hársing LG; Szénási G
Br J Pharmacol; 2007 Sep; 152(1):151-60. PubMed ID: 17603549
[TBL] [Abstract][Full Text] [Related]
15. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures.
Sanchez RM; Koh S; Rio C; Wang C; Lamperti ED; Sharma D; Corfas G; Jensen FE
J Neurosci; 2001 Oct; 21(20):8154-63. PubMed ID: 11588188
[TBL] [Abstract][Full Text] [Related]
16. The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia.
Erdo F; Berzsenyi P; Andrási F
Brain Res Bull; 2005 Jul; 66(1):43-9. PubMed ID: 15925143
[TBL] [Abstract][Full Text] [Related]
17. Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA- and AMPA receptor antagonists.
Berg M; Bruhn T; Johansen FF; Diemer NH
Pharmacol Toxicol; 1993 Nov; 73(5):262-8. PubMed ID: 8115308
[TBL] [Abstract][Full Text] [Related]
18. Effects of hypoxia-induced neonatal seizures on acute hippocampal injury and later-life seizure susceptibility and anxiety-related behavior in mice.
Rodriguez-Alvarez N; Jimenez-Mateos EM; Dunleavy M; Waddington JL; Boylan GB; Henshall DC
Neurobiol Dis; 2015 Nov; 83():100-14. PubMed ID: 26341542
[TBL] [Abstract][Full Text] [Related]
19. The role of glutamate receptor maturation in perinatal seizures and brain injury.
Jensen FE
Int J Dev Neurosci; 2002; 20(3-5):339-47. PubMed ID: 12175872
[TBL] [Abstract][Full Text] [Related]
20. Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats.
Belayev L; Alonso OF; Liu Y; Chappell AS; Zhao W; Ginsberg MD; Busto R
J Neurotrauma; 2001 Oct; 18(10):1031-8. PubMed ID: 11686490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
